Serge Saxonov - 28 Dec 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
28 Dec 2021
Net transactions value
+$67,636
Form type
4
Filing time
30 Dec 2021, 18:32:23 UTC
Previous filing
09 Dec 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $67,636 +56,363 +6.4% $1.20* 934,218 28 Dec 2021 Direct
transaction TXG Class A Common Stock Gift $0 -360 -8% $0.000000 4,138 13 Dec 2021 See footnote F1
holding TXG Class A Common Stock 89,960 28 Dec 2021 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -56,363 -52% $0.000000 52,535 28 Dec 2021 Class A Common Stock 56,363 $1.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F2 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F3 This option, originally for 300,000 shares, of which 247,465 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.